Abstract
Treatment of acute pancreatitis (AP) is one of the critical challenges to the field of gastroenterology because of its high mortality rate and high medical costs associated with the treatment of severe cases. Early-phase treatments for AP have been optimized in Japan, and clinical guidelines have been provided. However, changes in early-phase treatments and the relationship between treatment strategy and clinical outcome remain unclear. Retrospective analysis of nationwide epidemiological data shows that time for AP diagnosis has shortened, and the amount of initial fluid resuscitation has increased over time, indicating the compliance with guidelines. In contrast, prophylactic use of broad-spectrum antibiotics has emerged. Despite the potential benefits of early enteral nutrition, its use is still limited. The roles of continuous regional arterial infusion in the improvement of prognosis and the prevention of late complications are uncertain. Furthermore, early-phase treatments have had little impact on late-phase complications, such as walled-off necrosis, surgery requirements and late (> 4 w) AP-related death. Based on these observations, early-phase treatments for AP in Japan have approached the optimal level, but late-phas...Continue Reading
References
Jun 4, 2004·BMJ : British Medical Journal·Paul E Marik, Gary P Zaloga
May 31, 2006·World Journal of Gastroenterology : WJG·Makoto OtsukiUNKNOWN Research Committee of Intractable Diseases of the Pancreas
Mar 25, 2009·Journal of Gastroenterology·Takashi UedaHarumasa Ohyanagi
Jan 30, 2010·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Timothy B GardnerMichael G Sarr
Apr 23, 2010·The New England Journal of Medicine·Hjalmar C van SantvoortUNKNOWN Dutch Pancreatitis Study Group
May 1, 2010·Pancreas·Marta PiaścikAntoni Gabryelewicz
Dec 17, 2010·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Damian J MoleRowan W Parks
Apr 19, 2011·Pancreas·Kennichi SatohUNKNOWN Research Committee of Intractable Diseases of the Pancreas
Mar 20, 2012·Gastroenterology·Rawad MounzerGeorgios I Papachristou
May 10, 2012·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Povilas IgnataviciusGiedrius Barauskas
Oct 27, 2012·Gut·Peter A BanksUNKNOWN Acute Pancreatitis Classification Working Group
May 30, 2013·World Journal of Gastroenterology : WJG·B W Marcel SpanierMarcel G W Dijkgraaf
Jun 14, 2013·PloS One·Jie-Yao LiQi-Kui Chen
Jun 29, 2013·Endoscopy·I YasudaT Shimosegawa
Oct 15, 2013·World Journal of Gastroenterology : WJG·Makoto OtsukiYoshifumi Takeyama
Apr 4, 2014·Pancreas·Julia McNabb-BaltarPeter A Banks
Aug 2, 2014·Pancreas·Shin HamadaUNKNOWN Research Committee of Intractable Diseases of the Pancreas
May 15, 2015·Journal of Hepato-biliary-pancreatic Sciences·Masamichi YokoeKoichi Hirata
Aug 27, 2015·World Journal of Gastroenterology : WJG·Michal LipinskiGrazyna Rydzewska
Sep 2, 2015·The American Journal of Gastroenterology·Haq NawazGeorgios I Papachristou
Jan 19, 2016·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Janneke van GrinsvenUNKNOWN Dutch Pancreatitis Study Group
Apr 30, 2016·The American Journal of Gastroenterology·Shin HamadaTooru Shimosegawa
Jun 3, 2016·Pancreas·Cécile GomercicXavier Hébuterne
Sep 9, 2016·World Journal of Gastroenterology : WJG·Shin HamadaTooru Shimosegawa
Dec 14, 2016·The New England Journal of Medicine·Chris E ForsmarkC Mel Wilcox
Dec 16, 2016·Pancreas·Masayasu HoribeTakanori Kanai
Dec 22, 2016·The Journal of Antimicrobial Chemotherapy·Elda RighiDavid L Paterson
Jan 14, 2017·Pancreas·Shin HamadaTooru Shimosegawa